Post-traumatic Stress Disorder (PTSD) Clinical Trial
Official title:
A Hybrid Effectiveness-Implementation Trial of Treatments for Veterans With PTSD at Elevated Acute Risk for Suicide
Posttraumatic Stress Disorder (PTSD) is a significant driver of suicide risk among Veterans, but there is a critical knowledge gap about how to treat PTSD among people at elevated risk for suicide. Although evidence-based treatments for PTSD reduce suicide risk, Veterans at high risk for suicidal behavior rarely receive these potentially life-saving treatments. Prior research suggests that a treatment that combines Dialectical Behavior Therapy (DBT) with the DBT Prolonged Exposure protocol (DBT PE) for PTSD improves both PTSD and suicide-related outcomes. This study will evaluate whether DBT + DBT PE improves these outcomes more than Prolonged Exposure plus suicide risk management, the gold standard VA care for this population. The proposed study will also examine factors that make it easier and harder to implement these treatments in VA settings. The results will help to inform treatment guidelines for this high-priority Veteran population.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | July 30, 2027 |
Est. primary completion date | April 30, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - PTSD - Recent and repeated self-directed violence - Current suicidal ideation - Emotion dysregulation - Veteran eligible for VHA mental health care at participating site (Seattle, Minneapolis, and Durham VAs) - Age 18+ - Willing to participate in all study activities Exclusion Criteria: - Unable to maintain safety independently - Currently engaged in and/or recent (past year) history of receiving a sufficient dose of DBT or PE - Plan to move away or be unavailable for >4 weeks in the next 18 months - Unable to sufficiently comprehend study procedures due to lack of English proficiency or moderate to severe cognitive impairment |
Country | Name | City | State |
---|---|---|---|
United States | Durham VA Medical Center, Durham, NC | Durham | North Carolina |
United States | Minneapolis VA Health Care System, Minneapolis, MN | Minneapolis | Minnesota |
United States | VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Treatment History Interview (THI) | Non-VA psychotherapy, psychiatric crisis services, and psychotropic medications | Baseline to 18 months | |
Other | VA Service Use Form | VA mental health service use and psychotropic medications | Baseline to 18 months | |
Other | Credibility Expectancy Questionnaire (CEQ) | Total score (range = 1 - 7, higher is better) | Baseline to 18 months | |
Other | Client Satisfaction Questionnaire (CSQ) | Total score (range = 8 - 32, higher is better) | Post-treatment (4 months in PE + SRM, 12 months in DBT + DBT PE) | |
Other | Dissociative Experiences Scale - Taxon (DES-T) | Total score (range = 0 - 80, higher is worse) | Baseline to 18 months | |
Other | Trauma-Related Shame Inventory (TRSI) | Total score (range = 0 - 72, higher is worse) | Baseline to 18 months | |
Other | Self-Compassion Scale (SCS) | Total score (range = 1 - 5, higher is better) | Baseline to 18 months | |
Other | Borderline Symptom List - Behavioral Supplement (BSL-BS) | Total score (range = 0 - 44, higher is worse) | Baseline to 18 months | |
Other | PTSD Checklist for DSM-5 (PCL-5) | Total severity score (range = 0 - 80, higher is worse) | Baseline to 18 months | |
Other | Post-Traumatic Cognitions Inventory-9 (PTCI-9) | Total score (range = 9 to 63, higher is worse) | Baseline to 18 months | |
Primary | Self-Injurious Thoughts and Behaviors Interview - Revised Short Form (SITBI-R-SF) | Number of self-directed violence episodes | Baseline to 18 months | |
Primary | Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) | Total Severity Score (range = 0 - 200, higher is worse) | Baseline to 18 months | |
Secondary | Columbia - Suicide Severity Rating Scale (C-SSRS), Suicide Ideation subscales | Total Score (range = 0 - 5, higher is worse) | Baseline to 18 months | |
Secondary | Brief Symptom Inventory (BSI) | Global Severity Index (range = 0 to 4, higher is worse) | Baseline to 18 months | |
Secondary | Difficulties in Emotion Regulation Scale-16 (DERS-16) | Total Score (range = 16 - 80, higher is worse) | Baseline to 18 months | |
Secondary | World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) | General Disability Score (range = 12 - 60, higher is worse) | Baseline to 18 months | |
Secondary | Self-Injurious Thoughts and Behaviors Interview Revised Short Form (SITBI-R-SF) | Non-suicidal self-injury frequency and remission; Suicide attempt frequency and remission | Baseline to 18 months | |
Secondary | Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) | PTSD diagnostic status | Baseline to 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05189977 -
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
|
Phase 1 | |
Completed |
NCT01806168 -
rTMS in the Treatment of PTSD
|
N/A | |
Not yet recruiting |
NCT06194851 -
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
|
Phase 2 | |
Completed |
NCT02187224 -
Progesterone Effect on Individuals Diagnoses With AD and PTSD.
|
Phase 2/Phase 3 | |
Completed |
NCT02549508 -
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
|
N/A | |
Completed |
NCT02012738 -
Treatment of Trauma and Violence in the Townships of South Africa
|
N/A | |
Not yet recruiting |
NCT01940549 -
Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder
|
N/A | |
Not yet recruiting |
NCT06419959 -
NightWare and Cardiovascular Health in Veterans With PTSD
|
N/A | |
Terminated |
NCT03209882 -
Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT04891614 -
The PRISM Pilot Trial for Post-Traumatic Stress Disorder
|
N/A | |
Recruiting |
NCT05407337 -
The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme
|
N/A | |
Completed |
NCT02030522 -
Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma
|
N/A | |
Completed |
NCT01729325 -
Prevention of Post-Traumatic Stress Disorder in Soldiers
|
Phase 2 | |
Completed |
NCT02053532 -
Functional Brain Imaging in PTSD
|
N/A | |
Not yet recruiting |
NCT02598024 -
Treating Earthquake in Nepal Trauma (TENT) Trial 2016
|
N/A | |
Terminated |
NCT02237703 -
Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
Withdrawn |
NCT02356861 -
LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans
|
N/A | |
Not yet recruiting |
NCT06288594 -
TraumaRelief App: A Pilot RCT Assessing Feasibility and Acceptability
|
N/A | |
Completed |
NCT01847469 -
Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence
|
Phase 2 | |
Completed |
NCT01691092 -
PET Imaging of mGLuR5 With Drug Challenge
|
N/A |